Back
Pieris Pharmaceuticals Stock Price Chart
Sponsored
PIRS
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
45
PIRS
Pieris Pharmaceuticals
Last Price:
16.95
Seasonality Move:
9.58%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- The current trend is moderately bullish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.
Pieris Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.01 | Sell |
20-day SMA: | 16.71 | Buy |
50-day SMA: | 16.89 | Buy |
200-day SMA: | 13.65 | Buy |
8-day EMA: | 16.98 | Sell |
20-day EMA: | 16.83 | Buy |
50-day EMA: | 16.39 | Buy |
200-day EMA: | 17.6 | Sell |
Pieris Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 53.68 | Buy |
Chaikin Money Flow: | -17354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.29 - 16.99) | Buy |
Bollinger Bands (100): | (10.7 - 18.38) | Buy |
Pieris Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pieris Pharmaceuticals Stock
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 16.98 while PIRS 8-day simple moving average is 17.01, which is a Sell signal.
- The stock price of PIRS is 16.98 while Pieris Pharmaceuticals 20-day SMA is 16.71, which makes it a Buy.
- Pieris Pharmaceuticals 50-day simple moving average is 16.89 while PIRS share price is 16.98, making it a Buy technically.
- PIRS stock price is 16.98 and Pieris Pharmaceuticals 200-day simple moving average is 13.65, creating a Buy signal.
PIRS Technical Analysis vs Fundamental Analysis
Sell
45
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy or a Sell?
-
Pieris Pharmaceuticals stock is rated a Sell
The current Pieris Pharmaceuticals [PIRS] share price is $16.98. The Score for PIRS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Pieris Pharmaceuticals Stock Info
Market Cap:
22.42M
Price in USD:
16.98
Share Volume:
18.58K
Pieris Pharmaceuticals 52-Week Range
52-Week High:
23.20
52-Week Low:
6.20
Sell
45
Pieris Pharmaceuticals (PIRS)
is a Sell
Pieris Pharmaceuticals Share Price Forecast
-
What is the Pieris Pharmaceuticals stock price today?
The Pieris Pharmaceuticals stock price is 16.98 USD today. -
Will PIRS stock go up or go down?
Pieris Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Pieris Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pieris Pharmaceuticals is overvalued.
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 16.98 while PIRS 8-day exponential moving average is 16.98, which is a Sell signal.
- The stock price of PIRS is 16.98 while Pieris Pharmaceuticals 20-day EMA is 16.83, which makes it a Buy.
- Pieris Pharmaceuticals 50-day exponential moving average is 16.39 while PIRS share price is 16.98, making it a Buy technically.
- PIRS stock price is 16.98 and Pieris Pharmaceuticals 200-day simple moving average is 17.60, creating a Sell signal.
Fundamental Analysis of Pieris Pharmaceuticals
Is Pieris Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Pieris Pharmaceuticals
Should I short Pieris Pharmaceuticals stock?
- PIRS Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Pieris Pharmaceuticals is a Buy
- Pieris Pharmaceuticals Relative Strength Index (RSI) is 53.68, which suggest Pieris Pharmaceuticals is overbought
- The Bollinger Bands (25) for Pieris Pharmaceuticals is (16.29 - 16.99), which suggest Pieris Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Pieris Pharmaceuticals is (10.7 - 18.38), which suggest Pieris Pharmaceuticals is a Buy
* Pieris Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.